Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
During live demonstrations, industry leaders highlighted SEOPRO’s ability to spot portfolio risk, execution bottlenecks, and decision delays early—before they escalate into costly program disruptions
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The formulation is backed by over 80 clinical trials and 200 scientific publications
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
